Treatment for Neurogenic Bladder

Phase-Based Progress Estimates
Metrohealth Medical System, Cleveland, OHNeurogenic Bladder
All Sexes
What conditions do you have?

Study Summary

This trial will test a custom algorithm + wireless bladder pressure sensor for individuals with spinal cord injury to improve bladder control & urinary continence.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: within 1 week of signing consent form

Week 1
Comparison of bladder activity with and without genital nerve stimulation
Documentation of NDO with cystometrogram (urodynamics)
Week 2
successful reduction of neurogenic bladder spasms

Trial Safety

Trial Design

0 Treatment Group

12 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within 1 week of signing consent form

Who is running the clinical trial?

MetroHealth Medical CenterLead Sponsor
107 Previous Clinical Trials
20,882 Total Patients Enrolled
The Craig H. Neilsen FoundationOTHER
47 Previous Clinical Trials
2,562 Total Patients Enrolled
Dennis Bourbeau, PhDPrincipal InvestigatorMetroHealth Rehabilitation Institute of Ohio
2 Previous Clinical Trials
10 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a spinal cord injury above the level of the L5/S1 vertebrae.
You have reached full bone development.
Your neurological condition is not changing or getting worse.
You must have had your injury at least 6 months ago.